SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-048163
Filing Date
2024-04-25
Accepted
2024-04-25 15:00:29
Documents
74
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A vcnx-20231231.htm   iXBRL 10-K/A 1287810
2 EX-23.1 vcnx-ex23_1.htm EX-23.1 2874
3 EX-31.1 vcnx-ex31_1.htm EX-31.1 12394
4 EX-31.2 vcnx-ex31_2.htm EX-31.2 12141
5 EX-32.1 vcnx-ex32_1.htm EX-32.1 11568
6 EX-97 vcnx-ex97.htm EX-97 61921
  Complete submission text file 0000950170-24-048163.txt   7450488

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vcnx-20231231.xsd EX-101.SCH 1242106
78 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-20231231_htm.xml XML 1246597
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38624 | Film No.: 24875524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)